share_log

Credit Suisse Reiterates Outperform on Privia Health Gr, Maintains $41 Price Target

Credit Suisse Reiterates Outperform on Privia Health Gr, Maintains $41 Price Target

瑞士信貸重申Privia Health Gr跑贏大盤,維持41美元的目標股價
Benzinga ·  2023/05/08 07:41

Credit Suisse analyst Jonathan Yon reiterates Privia Health Gr (NASDAQ:PRVA) with a Outperform and maintains $41 price target.

瑞士信貸分析師喬納森·揚重申,Privia Health Gr(納斯達克股票代碼:PRVA)的表現跑贏大盤,並維持41美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論